Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/34221Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.referee | Hamza, Amir | - |
| dc.contributor.referee | Fornara, Paolo | - |
| dc.contributor.referee | Vordermark, Dirk | - |
| dc.contributor.referee | Stolzenburg, Jens-Uwe | - |
| dc.contributor.author | Albarghouth, Mohamad Hatem | - |
| dc.date.accessioned | 2020-08-25T12:58:42Z | - |
| dc.date.available | 2020-08-25T12:58:42Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.uri | https://opendata.uni-halle.de//handle/1981185920/34416 | - |
| dc.identifier.uri | http://dx.doi.org/10.25673/34221 | - |
| dc.description.abstract | Background und Objectives: We examined the effect of the photodynamic Diagnosis (PDD) by bladder cancer of the recurrence rate, residual tumor rate, and progression-free survival. Materials and methods: we retrospectively collected 98 patients. Patients were diagnosed with a primary bladder tumor by using either WL-TURB (49 patients) or BL-TURB with PDD (49 patients). Conclusion: Using the PDD (HAL) significantly reduces the risk of residual tumors. The 3- and 12-month recurrence-free survival and 1-year progression-free survival are significantly prolonged. | ger |
| dc.description.abstract | Background und Objectives: We examined the effect of the photodynamic Diagnosis (PDD) by bladder cancer of the recurrence rate, residual tumor rate, and progression-free survival. Materials and methods: we retrospectively collected 98 patients. Patients were diagnosed with a primary bladder tumor by using either WL-TURB (49 patients) or BL-TURB with PDD (49 patients). Conclusion: Using the PDD (HAL) significantly reduces the risk of residual tumors. The 3- and 12-month recurrence-free survival and 1-year progression-free survival are significantly prolonged. | eng |
| dc.format.extent | 1 Online-Ressource (93 Seiten) | - |
| dc.language.iso | ger | - |
| dc.rights.uri | http://rightsstatements.org/vocab/InC/1.0/ | - |
| dc.subject.ddc | 610 | - |
| dc.title | Analyse der Anwendung der intraoperativen photodynamischen Diagnostik beim Harnblasenkarzinom | ger |
| dcterms.dateAccepted | 2020-07-31 | - |
| dcterms.type | Hochschulschrift | - |
| dc.type | PhDThesis | - |
| dc.identifier.urn | urn:nbn:de:gbv:3:4-1981185920-344164 | - |
| local.versionType | publishedVersion | - |
| local.publisher.universityOrInstitution | Martin-Luther-Universität Halle-Wittenberg | - |
| local.subject.keywords | Ziel der Arbeit: Wir untersuchten die photodynamische Diagnostik (PDD) beim Harnblasenkarzinom hinsichtlich ihres Effekts auf Rezidiv-Rate, Residualtumor-Rate und progressionsfreies Überleben. Material und Methoden: Retrospektive Studie mit 98 Patienten, die entweder per WL-TURB (49 Patienten) oder BL-TURB mit PDD (49 Patienten) operiert wurden. Schlussfolgerung: Die PDD senkt signifikant Residualtumorerate. Das 3- sowie 12-Monates-rezidivfreie Überleben und das 1-Jahres-progressionfreie-Überleben werden signifikant verlängert. | - |
| local.subject.keywords | Hexvix®, Harnblasenkarzinom, Progression, Hexaminolevulinat, Residualtumor, Rezidiv, Blaulicht, Weißlicht | - |
| local.subject.keywords | Hexvix®, Bladder cancer, Progression, Hexaminolevulinat, residual tumor, Recurrence, Blue light, White light | - |
| local.openaccess | true | - |
| dc.identifier.ppn | 1727762428 | - |
| local.publication.country | XA-DE | - |
| cbs.sru.importDate | 2020-08-25T12:57:16Z | - |
| local.accessrights.dnb | free | - |
| Appears in Collections: | Interne-Einreichungen | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Diss_MLU_Albarghout_2020.pdf | 2.19 MB | Adobe PDF |  View/Open |